152 related articles for article (PubMed ID: 32245735)
1. Sequencing in management of in-transit melanoma metastasis: Diphencyprone versus isolate limb infusion.
Lo MC; Garioch J; Moncrieff MD
J Plast Reconstr Aesthet Surg; 2020 Jul; 73(7):1263-1267. PubMed ID: 32245735
[TBL] [Abstract][Full Text] [Related]
2. Responses to Topical Diphenylcyclopropenone as an Adjunct Treatment for In-Transit Melanoma: A Tertiary Referral Center Experience.
Veverka KK; Jakub JW; Baum CL
Dermatol Surg; 2018 Dec; 44(12):1501-1508. PubMed ID: 29985863
[TBL] [Abstract][Full Text] [Related]
3. First Eastern European experience of isolated limb infusion for in-transit metastatic melanoma confined to the limb: Is it still an effective treatment option in the modern era?
Teras J; Kroon HM; Thompson JF; Teras M; Pata P; Mägi A; Teras RM; Boudinot SR
Eur J Surg Oncol; 2020 Feb; 46(2):272-276. PubMed ID: 31748147
[TBL] [Abstract][Full Text] [Related]
4. Clinical Response and Regional Toxicity Following Isolated Limb Infusion Compared with Isolated Limb Perfusion for In-Transit Melanoma.
Dossett LA; Ben-Shabat I; Olofsson Bagge R; Zager JS
Ann Surg Oncol; 2016 Jul; 23(7):2330-5. PubMed ID: 26926481
[TBL] [Abstract][Full Text] [Related]
5. Diphenylcyclopropenone for the treatment of cutaneous in-transit melanoma metastases - results of a prospective, non-randomized, single-centre study.
Read T; Webber S; Tan J; Wagels M; Schaider H; Soyer HP; Smithers BM
J Eur Acad Dermatol Venereol; 2017 Dec; 31(12):2030-2037. PubMed ID: 28626861
[TBL] [Abstract][Full Text] [Related]
6. Patients with in-transit melanoma metastases have comparable survival outcomes following isolated limb infusion or intralesional PV-10-A propensity score matched, single center study.
Read T; Fayers W; Thomas J; Wagels M; Barbour A; Mark Smithers B
J Surg Oncol; 2019 May; 119(6):717-727. PubMed ID: 30644564
[TBL] [Abstract][Full Text] [Related]
7. Predicting disease progression after regional therapy for in-transit melanoma.
Lidsky ME; Turley RS; Beasley GM; Sharma K; Tyler DS
JAMA Surg; 2013 Jun; 148(6):493-8. PubMed ID: 23558401
[TBL] [Abstract][Full Text] [Related]
8. Topical diphencyprone immunotherapy for cutaneous metastatic melanoma.
Damian DL; Shannon KF; Saw RP; Thompson JF
Australas J Dermatol; 2009 Nov; 50(4):266-71. PubMed ID: 19916970
[TBL] [Abstract][Full Text] [Related]
9. Lesional therapies for in-transit melanoma.
Nadler A; Look Hong NJ; Alavi N; Abadir W; Wright FC
J Surg Oncol; 2020 Nov; 122(6):1050-1056. PubMed ID: 32668038
[TBL] [Abstract][Full Text] [Related]
10. Topical immunotherapy with diphencyprone (DPCP) for in-transit and unresectable cutaneous melanoma lesions: an inaugural Canadian series.
Yeung C; Petrella TM; Wright FC; Abadir W; Look Hong NJ
Expert Rev Clin Immunol; 2017 Apr; 13(4):383-388. PubMed ID: 28121191
[TBL] [Abstract][Full Text] [Related]
11. International Multicenter Experience of Isolated Limb Infusion for In-Transit Melanoma Metastases in Octogenarian and Nonagenarian Patients.
Teras J; Kroon HM; Miura JT; Kenyon-Smith T; Beasley GM; Mullen D; Farrow NE; Mosca PJ; Lowe MC; Farley CR; Potdar A; Daou H; Sun J; Carr M; Farma JM; Henderson MA; Speakman D; Serpell J; Delman KA; Smithers BM; Barbour A; Tyler DS; Coventry BJ; Zager JS; Thompson JF
Ann Surg Oncol; 2020 May; 27(5):1420-1429. PubMed ID: 32152775
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Oncologic Outcomes After Isolated Limb Infusion for Locoregionally Metastatic Melanoma: An International Multicenter Analysis.
Miura JT; Kroon HM; Beasley GM; Mullen D; Farrow NE; Mosca PJ; Lowe MC; Farley CR; Kim Y; Naqvi SMH; Potdar A; Daou H; Sun J; Farma JM; Henderson MA; Speakman D; Serpell J; Delman KA; Mark Smithers B; Coventry BJ; Tyler DS; Thompson JF; Zager JS
Ann Surg Oncol; 2019 Aug; 26(8):2486-2494. PubMed ID: 30911949
[TBL] [Abstract][Full Text] [Related]
13. Australian multi-center experience outside of the Sydney Melanoma Unit of isolated limb infusion chemotherapy for melanoma.
Coventry BJ; Kroon HM; Giles MH; Henderson M; Speakman D; Wall M; Barbour A; Serpell J; Paddle P; Coventry AG; Sullivan T; Smithers BM
J Surg Oncol; 2014 Jun; 109(8):780-5. PubMed ID: 24634160
[TBL] [Abstract][Full Text] [Related]
14. Use Patterns and Costs of Isolated Limb Perfusion and Infusion in the Treatment of Regional Metastatic Melanoma: A Retrospective Database Analysis.
Ma Q; Zhao Z; Barber BL; Shilkrut M
Adv Ther; 2016 Feb; 33(2):282-9. PubMed ID: 26797898
[TBL] [Abstract][Full Text] [Related]
15. Isolated limb infusion for malignant melanoma: predictors of response and outcome.
Barbour AP; Thomas J; Suffolk J; Beller E; Smithers BM
Ann Surg Oncol; 2009 Dec; 16(12):3463-72. PubMed ID: 19830498
[TBL] [Abstract][Full Text] [Related]
16. Factors predicting toxicity and response following isolated limb infusion for melanoma: An international multi-centre study.
Kenyon-Smith TJ; Kroon HM; Miura JT; Teras J; Beasley GM; Mullen D; Farrow NE; Mosca PJ; Lowe MC; Farley CR; Potdar A; Daou H; Sun J; Farma JM; Henderson MA; Speakman D; Serpell J; Delman KA; Smithers BM; Barbour A; Coventry BJ; Tyler DS; Zager JS; Thompson JF
Eur J Surg Oncol; 2020 Nov; 46(11):2140-2146. PubMed ID: 32739218
[TBL] [Abstract][Full Text] [Related]
17. Isolated limb infusion for melanoma: a simple alternative to isolated limb perfusion.
Mian R; Henderson MA; Speakman D; Finkelde D; Ainslie J; McKenzie A
Can J Surg; 2001 Jun; 44(3):189-92. PubMed ID: 11407828
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the efficacy and toxicity of upper extremity isolated limb infusion chemotherapy for melanoma: An Australian multi-center study.
Kroon HM; Coventry BJ; Henderson MA; Barbour A; Serpell J; Smithers BM; Thompson JF
Eur J Surg Oncol; 2019 May; 45(5):832-837. PubMed ID: 30867095
[TBL] [Abstract][Full Text] [Related]
19. Major amputation for irresectable extremity melanoma after failure of isolated limb infusion.
Kroon HM; Lin DY; Kam PC; Thompson JF
Ann Surg Oncol; 2009 Jun; 16(6):1543-7. PubMed ID: 19352777
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of repeat isolated limb infusion with melphalan and actinomycin D for recurrent melanoma.
Kroon HM; Lin DY; Kam PC; Thompson JF
Cancer; 2009 May; 115(9):1932-40. PubMed ID: 19288571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
